Principal Securities, Inc. Moderna, Inc. Transaction History
Principal Securities, Inc.
- $3.21 Trillion
- Q1 2024
A detailed history of Principal Securities, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 1,520 shares of MRNA stock, worth $184,132. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,520
Previous 1,987
23.5%
Holding current value
$184,132
Previous $198 Million
18.03%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding MRNA
# of Institutions
1,045Shares Held
245MCall Options Held
12.1MPut Options Held
9.34M-
Baillie Gifford & CO44.7MShares$5.41 Billion3.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA39MShares$4.73 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY25.4MShares$3.08 Billion0.06% of portfolio
-
State Street Corp Boston, MA14.5MShares$1.75 Billion0.07% of portfolio
-
Flagship Pioneering Inc. Cambridge, MA9.67MShares$1.17 Billion67.87% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $47.4B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...